Manufacturing roundup: Societal CDMO nets new customers; Chime Biologics gets the OK to manufacture antibodies
Societal CDMO has been awarded service contracts for three new customers. The agreements include an array of manufacturing services, for clinical trials, analytical methods, formulation …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.